Extended collaboration will further explore the capabilities of Medidata Platform from early-phase trials to post-marketing ...
Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve ...
In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights increased data management, DE&I, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback